A decision on the Pfizer-BioNTech vaccine for infants and children 6 months through 4 years of age has been postponed after the Food and Drug Administration (FDA) said on Friday that it needed more data on how well a third shot works for the age group.
In a striking reversal, the FDA said that they would wait for data on how well three doses of Pfizer-BioNTech’s coronavirus vaccine work in children younger than 5 before deciding whether to authorize the vaccine for that age group.
The FDA has cleared a new antibody drug, that targets the omicron variant, for adults and adolescent patients with mild-to-moderate cases.
What people are saying?
Terry Ebare No child needs this useless vaccine, ever! It’s does nothing it’s intended to do, so why on earth would anyone promote this to parents of children is hard to fathom.
Mark Fitzpatrick Well that will never do because the Biden Harris administration would never allow it to be used. They’ve already taken treatments from those that needed it in order to promote the VX so their bank accounts can increase.